Johnson & Johnson maintains temporary ban on vaccines, launches vaccination campaign for displaced Americans
An independent panel of medical experts in the United States has suggested that the decision to lift the ban on the use of a vaccine developed by Johnson & Johnson to combat the coronavirus be postponed until further notice.
Johnson & Johnson’s use of the vaccine was temporarily banned on Tuesday, as blood clots were reported in some patients.
The decision was made by the Immunization Advisory Committee of the Center for Disease Control and Prevention (CDC), an advisory committee on vaccines, during an emergency meeting on Wednesday.
On Tuesday, the CDC and the US Food and Drug Administration (FDA) temporarily banned the use of the vaccine after six such blood clots.
In those cases, women between the ages of 18 and 48 contracted a disease called cerebral venous thrombosis within 6 to 13 days of Johnson & Johnson’s Corona vaccine, in which blood clots form in parts of the brain. One of the women has died, while another is being treated at a hospital and is said to be in critical condition.
